• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the pathogenic mechanism of autoimmune diseases focusing on HHV-6 persistent infection in DIHS

Research Project

Project/Area Number 21K08306
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 53050:Dermatology-related
Research InstitutionNara Medical University

Principal Investigator

Hideo Asada  奈良県立医科大学, 医学部, 教授 (60252681)

Co-Investigator(Kenkyū-buntansha) 新熊 悟  奈良県立医科大学, 医学部, 准教授 (00613788)
森 康子  神戸大学, 医学研究科, 教授 (50343257)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2022: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2021: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords薬剤性過敏症症候群 / DIHS / ヒトヘルペスウイルス / HHV-6 / 持続感染 / 自己免疫疾患 / 再活性化 / シングルセルRNA-seq解析
Outline of Research at the Start

われわれはこれまでにDIHS後の自己免疫疾患の発症にHHV-6持続感染が密接に関与している可能性を見出した。そこで、本研究ではDIHSにおけるHHV-6持続感染が患者の免疫状態にいかなる影響をおよぼすのかを明らかにして、DIHS後の自己免疫疾患の発症機序を解明する。本研究により、薬剤アレルギーとHHV-6感染が複雑に絡み合ったDIHSの病態におけるHHV-6の役割の一端を明らかにできるとともに、DIHSに対する新たな治療戦略の基盤となる情報を得ることが期待できる。

Outline of Final Research Achievements

It is known that autoimmune diseases develop during the recovery period in DIHS, but the mechanism is unknown. We found that patients with persistent HHV-6 infection after DIHS develop autoimmune diseases at a high rate. In order to elucidate the mechanism of the development of autoimmune diseases in DIHS, we performed single-cell RNA sequencing analysis of PBMCs from the persistent infection group, which developed autoimmune diseases, and the transient group, which did not develop complications. As a result, we found that HHV-6 persists in CD4 central memory T cells in patients with persistent HHV-6 infection, and that there is a decrease in the number of monocyte-lineage cells and a decrease in gene expression related to phagocytosis and antigen presentation in the acute phase.

Academic Significance and Societal Importance of the Research Achievements

本研究の結果、DIHS後にHHV-6持続感染をきたし自己免疫疾患を発症した患者では、一過性感染患者と比較して、DIHS急性期に単球系細胞が減少し、貪食・抗原提示に関連する遺伝子発現の低下も認めたことから、発症早期の単球系細胞の機能低下がその後のHHV-6持続感染に関わっていることが示唆された。また、回復期にHHV-6がCD4 central memory T細胞に持続感染し、この細胞中で特定のHHV-6関連遺伝子の発現を認めたことからHHV-6持続感染T細胞が、自己免疫疾患の発症に何らかの役割を担っている可能性が推測され、本研究がDIHS後自己免疫疾患の解明に繋がるものと期待される。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (24 results)

All 2024 2023 2022 2021

All Journal Article (16 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 13 results,  Open Access: 10 results) Presentation (8 results) (of which Int'l Joint Research: 3 results,  Invited: 4 results)

  • [Journal Article] Clinical Profiles of Japanese Patients with Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 20232024

    • Author(s)
      Tsukagoshi E, Nakamura R, Kaniwa N, Sai K, Kikura-Hanajiri R, Matsunaga K, Abe R, Asada H, Saito Y
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 47 Issue: 1 Pages: 88-97

    • DOI

      10.1248/bpb.b23-00595

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2024-01-01
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions2023

    • Author(s)
      Fukunaga K, Tsukagoshi E, Kurata M, Mizukawa Y, Niihara H, Morita E, Watanabe Y, Yamaguchi Y, Watanabe H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Azukizawa H, Asada H, Hasegawa A, Hama N, Ozeki T, Mashimo Y, Sekine A, Matsunaga K, Tanaka Y, Nakamura R, Abe R, Mushiroda T, Saito Y.
    • Journal Title

      J Invest Dermatol.

      Volume: 144 Issue: 4 Pages: 908

    • DOI

      10.1016/j.jid.2023.09.282

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.2023

    • Author(s)
      Mizukawa Y, Hama N, Miyagawa F, Takahashi H, Ogawa Y, Kurata M, Asada H, Abe R, Shiohara T.
    • Journal Title

      J Allergy Clin Immunol Pract.

      Volume: 11(10) Issue: 10 Pages: 3169-3178

    • DOI

      10.1016/j.jaip.2023.06.065

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN.2023

    • Author(s)
      Hama N, Sunaga Y, French LE, Chen WT, Chung WH, Chu CY, Abe R. et al
    • Journal Title

      J Allergy Clin Immunol Pract.

      Volume: 11(10) Issue: 10 Pages: 3161-3168

    • DOI

      10.1016/j.jaip.2023.07.001

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Development of a new HISCL automated CXCL9 immunoassay.2023

    • Author(s)
      Hasegawa T, Yoshida M, Watanabe S, Kondo T, Asada H, Nakagawa A, Tomii K, Kameda M, Otsuka M, Kuronuma K, Chiba H, Katayanagi S, Miyazaki Y, Mori A.
    • Journal Title

      Sci Rep.

      Volume: 13 Issue: 1 Pages: 5342-5342

    • DOI

      10.1038/s41598-023-32513-8

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Validation of a genotyping technique for a surrogate marker of HLA-B<sup>∗</sup>58:01 for allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in the Japanese population2023

    • Author(s)
      Tsukagoshi E, Nakamura R, Tanaka Y, Maekawa K, Hiratsuka M, Asada H, Saito Y
    • Journal Title

      Drug Metabolism and Pharmacokinetics

      Volume: 49 Pages: 100495-100495

    • DOI

      10.1016/j.dmpk.2023.100495

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 薬剤性過敏症症候群診療ガイドライン20232023

    • Author(s)
      水川良子、濱 菜摘、新原寛之、宮川 史、橋爪秀夫、藤山幹子、高橋勇人、渡辺秀晃、大山 学、山口由衣、川村龍吉、野村尚史、椛島健治、末木博彦、森田栄伸、阿部理一郎、浅田秀夫
    • Journal Title

      日皮会誌

      Volume: 134 Pages: 559-580

    • Related Report
      2023 Annual Research Report
    • Open Access
  • [Journal Article] Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series2022

    • Author(s)
      Takei S, Hama N, Mizukawa Y, Takahashi H, Miyagawa F, Asada H, Abe R
    • Journal Title

      J Eur Acad Dermatol Venereol

      Volume: 36 Issue: 4

    • DOI

      10.1111/jdv.17838

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms2022

    • Author(s)
      Mitsui Y, Shinkuma S, Nakamura-Nishimura Y, Ommori R, Ogawa K, Miyagawa F, Mori Y, Tohyama M, Asada H
    • Journal Title

      J Allergy Clin Immunol Pract

      Volume: 10 Issue: 2 Pages: 585-565

    • DOI

      10.1016/j.jaip.2021.10.042

    • Related Report
      2022 Research-status Report 2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients.2022

    • Author(s)
      Sunaga Y, Hama N, Ochiai H, Kokaze A, Lee ES, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyamag M, Abe R, Hashizume H, Nakajima S, Nomurai T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niiharam H, Morita E, Sueki H.
    • Journal Title

      J Dermatol Sci.

      Volume: 107(2) Issue: 2 Pages: 75-81

    • DOI

      10.1016/j.jdermsci.2022.07.004

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Psoriatic Skin Lesions after Apalutamide Treatment2022

    • Author(s)
      Miyagawa F, Akioka N, Yoshida N, Ogawa K, Asada H
    • Journal Title

      Acta Derm Venereol

      Volume: 102 Pages: adv00659-adv00659

    • DOI

      10.2340/actadv.v102.858

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] DIHS とヘルペスウイルス2022

    • Author(s)
      浅田秀夫
    • Journal Title

      皮膚科

      Volume: 1 Pages: 789-795

    • Related Report
      2022 Research-status Report
  • [Journal Article] 【ウイルスと皮膚疾患-新しい考え方】知っておきたいウイルスの話題 DIHS 最近の話題.2022

    • Author(s)
      浅田秀夫
    • Journal Title

      Visual Dermatology.

      Volume: 21 Pages: 1017-1019

    • Related Report
      2022 Research-status Report
  • [Journal Article] Japanese Research Committee on Severe Cutaneous Adverse Reaction. Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.2021

    • Author(s)
      Kinoshita F, Yokota I, Mieno H, Ueta M, Bush J, Kinoshita S, Sueki H, Asada H, Morita E, Fukushima M, Sotozono C, Teramukai S
    • Journal Title

      PLoS One.

      Volume: 16 Issue: 12 Pages: e0260730-e0260730

    • DOI

      10.1371/journal.pone.0260730

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chemokines in Severe Cutaneous Adverse Reactions (SCARs)2021

    • Author(s)
      Miyagawa F, Asada H
    • Journal Title

      Biomolecules

      Volume: 11 Issue: 6 Pages: 847-847

    • DOI

      10.3390/biom11060847

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).2021

    • Author(s)
      Miyagawa F, Asada H
    • Journal Title

      Int J Mol Sci.

      Volume: 22 Issue: 4 Pages: 2147-2147

    • DOI

      10.3390/ijms22042147

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Pathological implications of persistent HHV-6 infection in DIHS/DRESS2023

    • Author(s)
      H Asada
    • Organizer
      iSCAR2023 Meeting
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Biomarkers of DIHS/DRESS.2022

    • Author(s)
      Asada H
    • Organizer
      9th Drug Hypersensitivity Meeting
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] Early Diagnostic and Prognostic Biomarkers for DIHS/DRESS.2022

    • Author(s)
      Asada H
    • Organizer
      DRESS Syndrome Global Conference 2022
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] Combination of TARC and soluble OX40 in the diagnosis of DIHS/DRESS.2022

    • Author(s)
      Mitsui Y, Shinkuma S, Nakamura-Nishimura Y, Ommori R, Ogawa K, Miyagawa F, Asada H
    • Organizer
      日本研究皮膚科学会
    • Related Report
      2022 Research-status Report
  • [Presentation] 薬剤性過敏症症候群におけるHHV-6の病的意義2021

    • Author(s)
      浅田秀夫
    • Organizer
      第120回日本皮膚科学会総会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] 重症薬疹の最新の知見-薬剤性過敏症症候群の病態と診断-2021

    • Author(s)
      浅田秀夫
    • Organizer
      第7回総合アレルギー講習会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] Persistent HHV-6 infection has an increased risk of autoimmune disorders in patients with DIHS.2021

    • Author(s)
      Nishimura Y, Shobatake C, Miyagawa F, Shinkuma S, Watanabe H, Kira M, Nakajima S, Higashi Y, Asada H
    • Organizer
      The 46th annual meeting of the Japanese Society for Investigative Dermatology
    • Related Report
      2021 Research-status Report
  • [Presentation] Cutaneous adverse events caused by EGFR inhibitors may result from reduced expression of human β-defensins induced by staphylococci.2021

    • Author(s)
      Ommori R, Nishimura Y, Miyagawa F, Shobatake C, Ogawa K, Shinkuma S, Asada H
    • Organizer
      The 46th annual meeting of the Japanese Society for Investigative Dermatology
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi